Regeneron Pharmaceuticals (REGN)

Cash & Short-Term Investments

$7.99B

Quarterly · Period ending: · USD

REGN logo

REGN Cash & Short-Term Investments

Latest reported$7.99B
REGN Quarterly Cash & Short-Term Investments ($21.80M → $7.99B)
High-resolution chart · PNG

REGN cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
7,994,600,000
8,753,700,000
8,605,200,000
8,443,600,000
7,469,600,000
8,349,400,000
9,012,500,000
9,796,500,000
9,809,000,000
10,519,500,000
10,844,800,000
9,913,600,000
8,927,700,000
8,959,700,000
7,742,300,000
7,021,700,000
7,566,400,000
7,050,600,000
5,694,700,000
5,787,600,000
3,910,800,000
3,503,800,000
3,587,000,000
3,025,900,000
3,144,200,000
4,003,400,000
3,214,300,000
2,877,900,000
2,669,700,000
3,232,400,000
2,809,900,000
2,192,152,000
1,683,518,000
1,624,952,000
1,409,500,000
1,378,944,000
1,267,850,000
1,307,084,000
1,038,684,000
1,408,391,000
1,045,164,000
849,179,000
1,045,223,000
895,642,000
604,248,000
742,164,000
900,480,000
1,042,204,000
816,909,000
648,133,000
693,984,000
445,323,000
537,506,000
307,710,000
308,095,000
262,552,000
301,022,000
432,298,000
526,942,000
245,498,000
309,683,000
226,441,000
249,368,000
479,053,000
306,337,000
303,639,000
341,330,000
379,796,000
391,918,000
415,882,000
474,750,000
663,608,000
700,404,000
743,248,000
766,457,000
396,982,000
460,697,000
452,394,000
459,276,000
261,889,000
273,576,000
302,393,000
298,545,000
307,542,000
335,813,000
353,906,000
295,982,000
278,715,000
344,050,000
320,736,000
293,774,000
384,673,000
273,874,000
311,990,000
264,271,000
299,891,000
298,705,000
325,070,000
385,079,000
240,709,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.